Global Encephalitis Treatment Market, By Type (Primary Encephalitis, Secondary Encephalitis), Treatment (Antiviral Agents, Steroid Injection, Antibiotics, Immunoglobulin Therapy, Plasmapheresis, Others), Diagnosis (Imaging Tests, Blood Tests, Biopsy, Others), Symptoms (Fever, Drowsiness, Headaches, Personality Changes, Irritability, Confusion, Weakness, Seizures, Others), Dosage (Injection, Tablets, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) - Industry Trends and Forecast to 2029.
Market Analysis and Size
In recent years, the market for encephalitis treatment is estimated to grow rapidly due to prevalence of viral or bacterial infection. All these factors result in the higher risk of encephalitis which propel the treatment demand. This will contribute in the market’s revenue growth and enhances the market’s demand.
- Encephalitis is an infection or an inflammatory response that causes inflammation of the active tissues of the brain. The encephalitis treatment's purpose is to minimize head swelling and avoid unwanted problems. If encephalitis is caused by a bacterial infection, intravenous antibiotics can be used to treat it. Supportive treatment, as well as intravenous antiviral medication with acyclovir, are used to treat herpes-related encephalitis. Other therapies include lowering the fever, hydrating the patient, treating seizures if they occur, and reducing any pressure in the skull.
- Data Bridge Market Research analyses that the encephalitis treatment market will grow at a CAGR of 5.20% during the forecast period of 2022 to 2029. Antiviral segment holds the largest share of encephalitis treatment market followed by anticonvulsant drugs of treatment segment due to the increasing prevalence of viral infections and seizures respectively.
Encephalitis Treatment Market Dynamics
Drivers
- Increase in cancer incidence rate
The rise in the incidences of cancer will act as a major driver that will result in the expansion of the growth rate of the market. When your body is fighting cancer, certain immune system illnesses might induce encephalitis which will increases occurrence rate of encephalitis.
- Increasing investment for healthcare infrastructure
Another significant factor influencing the growth rate of encephalitis treatment market is the rising healthcare expenditure which helps in improving its infrastructure.
Also, the increase in the popularity of physical therapy across the globe will enhance the growth of encephalitis treatment market. Furthermore, rising initiatives by public and private organizations to spread awareness and growing government funding are the factors that will expand the encephalitis treatment market. Other factors such as an increase in the demand for effective therapies and rising spending on public health programs will positively impact the encephalitis treatment market's growth rate. Additionally, high disposable income, rising geriatric population, and changing lifestyle will result in the expansion of the encephalitis treatment market.
Opportunities
- Rise in the investment for R&D by public and private organizations
Moreover, the rise in the research and development activities and increasing investments by government and private organization will boost new opportunities for the market's growth rate.
Also, high unmet need of current treatment and developments in healthcare technology will provide beneficial opportunities for the encephalitis treatment market in the forecast period of 2022-2029.
Restraints/Challenges
However, high cost associated with the treatment and lack of infrastructure in low-income countries will impede the growth rate of encephalitis treatment market. Additionally, the dearth of skilled professionals will hinder the encephalitis treatment market growth. Emergence of unfavorable conditions due to COVID-19 outbreak and less awareness in patients will further challenge the market in the forecast period mentioned above.
This encephalitis treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on encephalitis treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Patient Epidemiology Analysis
Encephalitis affects 10–15 persons per 100,000 each year, with over 250,000 cases diagnosed in the United States in the last decade. The illness can affect anyone, but it is more common in children and teenagers. The HIV-infected population accounts for about 15% of encephalitis cases.
Encephalitis treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
COVID-19 Impact on Encephalitis Treatment Market
Due to the financial crisis and the delay in specialty healthcare delivery while prioritizing COVID-19-related treatments, healthcare systems around the world have been severely disrupted in the aftermath of the coronavirus pandemic. The crisis and its consequences have resulted in a worldwide drop in cancer care or a deferral of tumor surgery. Such considerations may have a negative impact on the market of encephalitis treatment.
Recent Development
- In August 2021, Pfizer had received United States Food and Drug Administration (USFDA) approval for Tick-Borne Encephalitis (TBE) Vaccine named TICOVAC. It can produce neutralizing antibodies against the TBE virus in the wild. TICOVAC contains albumin, a human blood product. It carries a very low risk of transmission of viral illness and variant Creutzfeldt-Jakob disease (vCJD) transmission because of efficient donor screening and product production processes.
Global Encephalitis Treatment Market Scope
The encephalitis treatment market is segmented on the basis of type, treatment, diagnosis, symptoms, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Primary Encephalitis
- Secondary Encephalitis
On the basis of type, the encephalitis treatment market is segmented into primary encephalitis, and secondary encephalitis.
Treatment
- Antiviral Agents
- Steroid Injection
- Antibiotics
- Immunoglobulin Therapy
- Plasmapheresis
- Others
On the basis of treatment, the encephalitis treatment market is segmented into antiviral agents, steroid injection, antibiotics, immunoglobulin therapy, plasmapheresis and others.
Diagnosis
- Imaging Tests
- Blood Tests, Biopsy
- Others
On the basis of diagnosis, the encephalitis treatment market is segmented into imaging tests, blood tests, biopsy and others. Imaging tests segment is further segmented into magnetic resonance imaging (MRI), spinal tap, and electroencephalogram (EEG).
Symptoms
- Fever
- Drowsiness
- Headaches
- Personality Changes
- Irritability
- Confusion
- Weakness
- Seizures
- Others
On the basis of symptoms, the encephalitis treatment market is segmented into fever, drowsiness, headaches, personality changes, irritability, confusion, weakness, seizures and others.
Dosage
- Injection
- Tablets
- Others
On the basis of dosage, the encephalitis treatment market is segmented into injection, tablets and others.
Route of Administration
- Oral
- Parenteral
- Others
On the basis of route of administration, the encephalitis treatment market is segmented into oral, parenteral and others.
End-Users
- Clinic
- Hospital
- Others
On the basis of end-users, the encephalitis treatment market is segmented into clinic, hospital and others.
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
The encephalitis treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Encephalitis Treatment Market Regional Analysis/Insights
The encephalitis treatment market is analysed and market size insights and trends are provided by country, type, treatment, diagnosis, symptoms, dosage, route of administration, end-users and distribution channel as referenced above.
The countries covered in the encephalitis treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the encephalitis treatment market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the presence of major key players and well-developed healthcare infrastructure in this region.
Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period due to the increasing patient pool, rising investment in the healthcare sector and growing government support.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Encephalitis Treatment Market Share Analysis
The encephalitis treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to encephalitis treatment market.
Some of the major players operating in the encephalitis treatment market are Allergan, Merck & Co., Inc., Pfizer Inc., GlaxoSmithKline plc, Melinta Therapeutics LLC, Basilea Pharmaceutica Ltd., Abbott, F. Hoffmann-La Roche Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Novartis AG, Bayer AG, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Lupin, AbbVie Inc., Cumberland Pharmaceuticals Inc., Eli Lilly and Company, Endo International plc, Zydus Cadila, and Fresenius Kabi AG, among others.
SKU-